Cited by 60Liver Disease Diagnosis and TreatmentCircadian rhythm and melatoninDietary Effects on Health

The effect of melatonin on treatment of patients with non-alcoholic fatty liver disease: a randomized double blind clinical trial

Bahrami, Mina, Cheraghpour, Makan, Jafarirad, Sima, Alavinejad, Pejman, Asadi, Fariba, Hekmatdoost, Azita, Mohammadi, Mahsa, Yari, Zahra·2020·Complementary Therapies in Medicine

Abstract

Objectives Many factors implicated in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) are including oxidative stress, insulin resistance and abnormal production of adipokines. The aim of this clinical trial was to evaluate the effect of melatonin supplement on some important biochemical markers and signs related to NAFLD.Design A randomized double-blind, placebo-controlled, clinical trial.Setting Twenty-four participants in the melatonin group and 21 participants in the placebo group completed the study.Intervention Participants received 6 mg melatonin or placebo daily, 1 h before bedtime. The intervention period was 12 weeks.Main outcome measures Anthropometric measurements, systolic and diastolic blood pressure, liver enzymes, high sensitive C‑reactive protein (hs-CRP), fatty liver grade, also leptin and adiponectin serum levels, were measured at the baseline and the end of intervention.Results A significant improvement was observed in weight (p = 0.043), waist circumference (p = 0.027), abdominal circumference (p = 0.043), systolic (p = 0.039), and diastolic (p = 0.015) blood pressure, leptin serum levels (p = 0.032), hs-CRP (p = 0.024), alanine aminotransferase (p = 0.011), aspartate aminotransferase (p = 0.034), also the grade of fatty liver (p = 0.020) in melatonin treated group compared with the placebo.Conclusions Administration of 6 mg/day melatonin had improvement effect on many factors related to NAFLD such as liver enzymes, hs-CRP, anthropometric measurements, blood pressure, leptin serum levels and the grade of fatty liver.

Integrity signals

Registry

Crossref · 10.1016/j.ctim.2020.102452

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

2 of the 44 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Bahrami, M., Cheraghpour, M., Jafarirad, S., Alavinejad, P., Asadi, F., Hekmatdoost, A., Mohammadi, M., & Yari, Z.
Affiliations
  • Ahvaz Jundishapur University of Medical Sciences (IR)
  • National Nutrition and Food Technology Research Institute (IR)
Corresponding author
Jafarirad, Sima
Venue
Complementary Therapies in Medicine
Publisher
Elsevier BV
Published
2020-08
Volume
52
Pages
102452
ISSN
0965-2299 (ISSN-L)
OpenAlex
W3028100062
Cited by
60
References
44
Citations by year
2026: 7 · 2025: 18 · 2024: 4 · 2023: 13 · 2022: 8 · 2021: 9 · 2020: 1
FWCI
5.55
Type
journal article
Language
en
Open access
closed
Locations
  • Complementary Therapies in Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Ahvaz Jundishapur University of Medical Sciences
Topics
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
  • Health Sciences › Medicine › Physiology › Dietary Effects on Health
Keywords
melatonin, non-alcoholic fatty liver disease, leptin, adiponectin, C-reactive protein, liver enzymes, alanine aminotransferase, aspartate aminotransferase, blood pressure, anthropometry, oxidative stress, insulin resistance, adipokines
MeSH terms
Adult, Antioxidants, Blood Pressure, Body Weights and Measures, Double-Blind Method, Female, Humans, Male, Melatonin, Middle Aged, Biomarkers, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review